Skip to main content
Top
Published in: BMC Cancer 1/2014

Open Access 01-12-2014 | Research article

Role of the microtubule-targeting drug vinflunine on cell-cell adhesions in bladder epithelial tumour cells

Authors: Luis A Aparicio, Raquel Castosa, Mar Haz-Conde, Marta Rodríguez, Moisés Blanco, Manuel Valladares, Angélica Figueroa

Published in: BMC Cancer | Issue 1/2014

Login to get access

Abstract

Background

Vinflunine (VFL) is a microtubule-targeting drug that suppresses microtubule dynamics, showing anti-metastatic properties both in vitro and in living cancer cells. An increasing body of evidence underlines the influence of the microtubules dynamics on the cadherin-dependent cell-cell adhesions. E-cadherin is a marker of epithelial-to-mesenchymal transition (EMT) and a tumour suppressor; its reduced levels in carcinoma are associated with poor prognosis. In this report, we investigate the role of VFL on cell-cell adhesions in bladder epithelial tumour cells.

Methods

Human bladder epithelial tumour cell lines HT1376, 5637, SW780, T24 and UMUC3 were used to analyse cadherin-dependent cell-cell adhesions under VFL treatment. VFL effect on growth inhibition was measured by using a MTT colorimetric cell viability assay. Western blot, immunofluorescence and transmission electron microscopy analyses were performed to assess the roles of VFL effect on cell-cell adhesions, epithelial-to-mesenchymal markers and apoptosis. The role of the proteasome in controlling cell-cell adhesion was studied using the proteasome inhibitor MG132.

Results

We show that VFL induces cell death in bladder cancer cells and activates epithelial differentiation of the remaining living cells, leading to an increase of E-cadherin-dependent cell-cell adhesion and a reduction of mesenchymal markers, such as N-cadherin or vimentin. Moreover, while E-cadherin is increased, the levels of Hakai, an E3 ubiquitin-ligase for E-cadherin, were significantly reduced in presence of VFL. In 5637, this reduction on Hakai expression was blocked by MG132 proteasome inhibitor, indicating that the proteasome pathway could be one of the molecular mechanisms involved in its degradation.

Conclusions

Our findings underscore a critical function for VFL in cell-cell adhesions of epithelial bladder tumour cells, suggesting a novel molecular mechanism by which VFL may impact upon EMT and metastasis.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Raghavan D, Shipley WU, Garnick MB, Russell PJ, Richie JP: Biology and management of bladder cancer. N Engl J Med. 1990, 322 (16): 1129-1138.CrossRefPubMed Raghavan D, Shipley WU, Garnick MB, Russell PJ, Richie JP: Biology and management of bladder cancer. N Engl J Med. 1990, 322 (16): 1129-1138.CrossRefPubMed
3.
go back to reference Stenzl A, Cowan NC, De Santis M, Jakse G, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA: The updated EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2009, 55 (4): 815-825.CrossRefPubMed Stenzl A, Cowan NC, De Santis M, Jakse G, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA: The updated EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2009, 55 (4): 815-825.CrossRefPubMed
4.
go back to reference Nollet F, Kools P, van Roy F: Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members. J Mol Biol. 2000, 299 (3): 551-572.CrossRefPubMed Nollet F, Kools P, van Roy F: Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members. J Mol Biol. 2000, 299 (3): 551-572.CrossRefPubMed
5.
go back to reference Perez-Moreno M, Jamora C, Fuchs E: Sticky business: orchestrating cellular signals at adherens junctions. Cell. 2003, 112 (4): 535-548.CrossRefPubMed Perez-Moreno M, Jamora C, Fuchs E: Sticky business: orchestrating cellular signals at adherens junctions. Cell. 2003, 112 (4): 535-548.CrossRefPubMed
6.
go back to reference Yonemura S: Cadherin-actin interactions at adherens junctions. Curr Opin Cell Biol. 2011, 23 (5): 515-522.CrossRefPubMed Yonemura S: Cadherin-actin interactions at adherens junctions. Curr Opin Cell Biol. 2011, 23 (5): 515-522.CrossRefPubMed
8.
go back to reference Yang J, Weinberg RA: Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell. 2008, 14 (6): 818-829.CrossRefPubMed Yang J, Weinberg RA: Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell. 2008, 14 (6): 818-829.CrossRefPubMed
9.
go back to reference Thiery JP, Acloque H, Huang RY, Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell. 2009, 139 (5): 871-890.CrossRefPubMed Thiery JP, Acloque H, Huang RY, Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell. 2009, 139 (5): 871-890.CrossRefPubMed
10.
go back to reference Yun SJ, Kim WJ: Role of the Epithelial-Mesenchymal Transition in Bladder Cancer: From Prognosis to Therapeutic Target. Korean J Urol. 2013, 54 (10): 645-650.CrossRefPubMedPubMedCentral Yun SJ, Kim WJ: Role of the Epithelial-Mesenchymal Transition in Bladder Cancer: From Prognosis to Therapeutic Target. Korean J Urol. 2013, 54 (10): 645-650.CrossRefPubMedPubMedCentral
11.
go back to reference Chen J, Han Q, Pei D: EMT and MET as paradigms for cell fate switching. J Mol Cell Biol. 2012, 4 (2): 66-69.CrossRefPubMed Chen J, Han Q, Pei D: EMT and MET as paradigms for cell fate switching. J Mol Cell Biol. 2012, 4 (2): 66-69.CrossRefPubMed
12.
go back to reference Birchmeier W, Behrens J: Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta. 1994, 1198 (1): 11-26.PubMed Birchmeier W, Behrens J: Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta. 1994, 1198 (1): 11-26.PubMed
13.
go back to reference Behrens J, Vakaet L, Friis R, Winterhager E, Van Roy F, Mareel MM, Birchmeier W: Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol. 1993, 120 (3): 757-766.CrossRefPubMed Behrens J, Vakaet L, Friis R, Winterhager E, Van Roy F, Mareel MM, Birchmeier W: Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol. 1993, 120 (3): 757-766.CrossRefPubMed
14.
go back to reference Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G: A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature. 1998, 392 (6672): 190-193.CrossRefPubMed Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G: A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature. 1998, 392 (6672): 190-193.CrossRefPubMed
15.
go back to reference Shimazui T, Schalken JA, Giroldi LA, Jansen CF, Akaza H, Koiso K, Debruyne FM, Bringuier PP: Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors. Cancer Res. 1996, 56 (18): 4154-4158.PubMed Shimazui T, Schalken JA, Giroldi LA, Jansen CF, Akaza H, Koiso K, Debruyne FM, Bringuier PP: Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors. Cancer Res. 1996, 56 (18): 4154-4158.PubMed
16.
go back to reference De Wever O, Pauwels P, De Craene B, Sabbah M, Emami S, Redeuilh G, Gespach C, Bracke M, Berx G: Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem Cell Biol. 2008, 130 (3): 481-494.CrossRefPubMedPubMedCentral De Wever O, Pauwels P, De Craene B, Sabbah M, Emami S, Redeuilh G, Gespach C, Bracke M, Berx G: Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem Cell Biol. 2008, 130 (3): 481-494.CrossRefPubMedPubMedCentral
17.
go back to reference Yilmaz M, Christofori G: EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 2009, 28 (1–2): 15-33.CrossRefPubMed Yilmaz M, Christofori G: EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 2009, 28 (1–2): 15-33.CrossRefPubMed
18.
go back to reference Mendez MG, Kojima S, Goldman RD: Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. FASEB J. 2010, 24 (6): 1838-1851.CrossRefPubMedPubMedCentral Mendez MG, Kojima S, Goldman RD: Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. FASEB J. 2010, 24 (6): 1838-1851.CrossRefPubMedPubMedCentral
19.
go back to reference Aparicio LA, Valladares M, Blanco M, Alonso G, Figueroa A: Biological influence of Hakai in cancer: a 10-year review. Cancer Metastasis Rev. 2012, 31 (1-2): 375-386.CrossRefPubMedPubMedCentral Aparicio LA, Valladares M, Blanco M, Alonso G, Figueroa A: Biological influence of Hakai in cancer: a 10-year review. Cancer Metastasis Rev. 2012, 31 (1-2): 375-386.CrossRefPubMedPubMedCentral
20.
go back to reference Batlle E, Sancho E, Francí C, Domínguez D, Monfar M, Baulida J, García De Herreros A: The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000, 2 (2): 84-89.CrossRefPubMed Batlle E, Sancho E, Francí C, Domínguez D, Monfar M, Baulida J, García De Herreros A: The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000, 2 (2): 84-89.CrossRefPubMed
21.
go back to reference Fujita Y, Krause G, Scheffner M, Zechner D, Leddy H, Behrens J, Sommer T, Birchmeier W: Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol. 2002, 4 (3): 222-231.CrossRefPubMed Fujita Y, Krause G, Scheffner M, Zechner D, Leddy H, Behrens J, Sommer T, Birchmeier W: Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol. 2002, 4 (3): 222-231.CrossRefPubMed
22.
go back to reference Swaminathan G, Cartwright CA: Rack1 promotes epithelial cell-cell adhesion by regulating E-cadherin endocytosis. Oncogene. 2011, 31 (3): 376-389.CrossRefPubMed Swaminathan G, Cartwright CA: Rack1 promotes epithelial cell-cell adhesion by regulating E-cadherin endocytosis. Oncogene. 2011, 31 (3): 376-389.CrossRefPubMed
23.
go back to reference Janda E, Nevolo M, Lehmann K, Downward J, Beug H, Grieco M: Raf plus TGFbeta-dependent EMT is initiated by endocytosis and lysosomal degradation of E-cadherin. Oncogene. 2006, 25 (54): 7117-7130.CrossRefPubMed Janda E, Nevolo M, Lehmann K, Downward J, Beug H, Grieco M: Raf plus TGFbeta-dependent EMT is initiated by endocytosis and lysosomal degradation of E-cadherin. Oncogene. 2006, 25 (54): 7117-7130.CrossRefPubMed
24.
go back to reference Zhou WJ, Geng ZH, Chi S, Zhang W, Niu XF, Lan SJ, Ma L, Yang X, Wang LJ, Ding YQ, Geng JG: Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis. Cell Res. 2011, 21 (4): 609-626.CrossRefPubMedPubMedCentral Zhou WJ, Geng ZH, Chi S, Zhang W, Niu XF, Lan SJ, Ma L, Yang X, Wang LJ, Ding YQ, Geng JG: Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis. Cell Res. 2011, 21 (4): 609-626.CrossRefPubMedPubMedCentral
25.
go back to reference Figueroa A, Kotani H, Toda Y, Mazan-Mamczarz K, Mueller E, Otto A, Disch L, Norman M, Ramdasi R, Keshtgar M, Gorospe M, Fujita Y: Novel roles of hakai in cell proliferation and oncogenesis. Mol Biol Cell. 2009, 20 (15): 3533-3542.CrossRefPubMedPubMedCentral Figueroa A, Kotani H, Toda Y, Mazan-Mamczarz K, Mueller E, Otto A, Disch L, Norman M, Ramdasi R, Keshtgar M, Gorospe M, Fujita Y: Novel roles of hakai in cell proliferation and oncogenesis. Mol Biol Cell. 2009, 20 (15): 3533-3542.CrossRefPubMedPubMedCentral
26.
go back to reference Figueroa A, Fujita Y, Gorospe M: Hacking RNA: Hakai promotes tumorigenesis by enhancing the RNA-binding function of PSF. Cell Cycle. 2009, 8 (22): 3648-3651.CrossRefPubMedPubMedCentral Figueroa A, Fujita Y, Gorospe M: Hacking RNA: Hakai promotes tumorigenesis by enhancing the RNA-binding function of PSF. Cell Cycle. 2009, 8 (22): 3648-3651.CrossRefPubMedPubMedCentral
27.
go back to reference Rodríguez-Rigueiro T, Valladares-Ayerbes M, Haz-Conde M, Aparicio LA, Figueroa A: Hakai reduces cell-substratum adhesion and increases epithelial cell invasion. BMC Cancer. 2011, 11: 474-CrossRefPubMedPubMedCentral Rodríguez-Rigueiro T, Valladares-Ayerbes M, Haz-Conde M, Aparicio LA, Figueroa A: Hakai reduces cell-substratum adhesion and increases epithelial cell invasion. BMC Cancer. 2011, 11: 474-CrossRefPubMedPubMedCentral
28.
go back to reference Abella V, Valladares M, Rodriguez T, Haz M, Blanco M, Tarrío N, Iglesias P, Aparicio LA, Figueroa A: miR-203 Regulates Cell Proliferation through Its Influence on Hakai Expression. PLoS One. 2012, 7 (12): e52568-CrossRefPubMedPubMedCentral Abella V, Valladares M, Rodriguez T, Haz M, Blanco M, Tarrío N, Iglesias P, Aparicio LA, Figueroa A: miR-203 Regulates Cell Proliferation through Its Influence on Hakai Expression. PLoS One. 2012, 7 (12): e52568-CrossRefPubMedPubMedCentral
29.
go back to reference Jordan MA, Horwitz SB, Lobert S, Correia JJ: Exploring the mechanisms of action of the novel microtubule inhibitor vinflunine. Semin Oncol. 2008, 35 (3 Suppl 3): S6-S12.CrossRefPubMed Jordan MA, Horwitz SB, Lobert S, Correia JJ: Exploring the mechanisms of action of the novel microtubule inhibitor vinflunine. Semin Oncol. 2008, 35 (3 Suppl 3): S6-S12.CrossRefPubMed
30.
go back to reference Jordan MA, Wilson L: Microtubules as a target for anticancer drugs. Nat Rev Cancer. 2004, 4 (4): 253-265.CrossRefPubMed Jordan MA, Wilson L: Microtubules as a target for anticancer drugs. Nat Rev Cancer. 2004, 4 (4): 253-265.CrossRefPubMed
31.
go back to reference Gerullis H, Ecke T, Eimer C, Wishahi M, Otto T: Vinflunine as second-line treatment in platin-resistant metastatic urothelial carcinoma: a review. Anticancer Drugs. 2011, 22 (1): 9-17.CrossRefPubMed Gerullis H, Ecke T, Eimer C, Wishahi M, Otto T: Vinflunine as second-line treatment in platin-resistant metastatic urothelial carcinoma: a review. Anticancer Drugs. 2011, 22 (1): 9-17.CrossRefPubMed
32.
go back to reference Gerullis H: Vinflunine: a fluorinated vinca alkaloid for bladder cancer therapy. Drugs Today (Barc). 2011, 47 (1): 17-25.CrossRef Gerullis H: Vinflunine: a fluorinated vinca alkaloid for bladder cancer therapy. Drugs Today (Barc). 2011, 47 (1): 17-25.CrossRef
33.
go back to reference Aparicio LM, Pulido EG, Gallego GA: Vinflunine: a new vision that may translate into antiangiogenic and antimetastatic activity. Anticancer Drugs. 2012, 23 (1): 1-11.CrossRefPubMed Aparicio LM, Pulido EG, Gallego GA: Vinflunine: a new vision that may translate into antiangiogenic and antimetastatic activity. Anticancer Drugs. 2012, 23 (1): 1-11.CrossRefPubMed
34.
go back to reference Pasquier E, Honoré S, Braguer D: Microtubule-targeting agents in angiogenesis: where do we stand?. Drug Resist Updat. 2006, 9 (1–2): 74-86.CrossRefPubMed Pasquier E, Honoré S, Braguer D: Microtubule-targeting agents in angiogenesis: where do we stand?. Drug Resist Updat. 2006, 9 (1–2): 74-86.CrossRefPubMed
36.
go back to reference Honoré S, Pagano A, Gauthier G, Bourgarel-Rey V, Verdier-Pinard P, Civiletti K, Kruczynski A, Braguer D: Antiangiogenic vinflunine affects EB1 localization and microtubule targeting to adhesion sites. Mol Cancer Ther. 2008, 7 (7): 2080-2089.CrossRefPubMed Honoré S, Pagano A, Gauthier G, Bourgarel-Rey V, Verdier-Pinard P, Civiletti K, Kruczynski A, Braguer D: Antiangiogenic vinflunine affects EB1 localization and microtubule targeting to adhesion sites. Mol Cancer Ther. 2008, 7 (7): 2080-2089.CrossRefPubMed
37.
go back to reference Akhmanova A, Yap AS: Organizing junctions at the cell-cell interface. Cell. 2008, 135 (5): 791-793.CrossRefPubMed Akhmanova A, Yap AS: Organizing junctions at the cell-cell interface. Cell. 2008, 135 (5): 791-793.CrossRefPubMed
38.
go back to reference Akhmanova A, Stehbens SJ, Yap AS: Touch, grasp, deliver and control: functional cross-talk between microtubules and cell adhesions. Traffic. 2009, 10 (3): 268-274.CrossRefPubMed Akhmanova A, Stehbens SJ, Yap AS: Touch, grasp, deliver and control: functional cross-talk between microtubules and cell adhesions. Traffic. 2009, 10 (3): 268-274.CrossRefPubMed
39.
go back to reference Stehbens SJ, Paterson AD, Crampton MS, Shewan AM, Ferguson C, Akhmanova A, Parton RG, Yap AS: Dynamic microtubules regulate the local concentration of E-cadherin at cell-cell contacts. J Cell Sci. 2006, 119 (Pt 9): 1801-1811.CrossRefPubMed Stehbens SJ, Paterson AD, Crampton MS, Shewan AM, Ferguson C, Akhmanova A, Parton RG, Yap AS: Dynamic microtubules regulate the local concentration of E-cadherin at cell-cell contacts. J Cell Sci. 2006, 119 (Pt 9): 1801-1811.CrossRefPubMed
40.
go back to reference Stehbens SJ, Akhmanova A, Yap AS: Microtubules and cadherins: a neglected partnership. Front Biosci (Landmark Ed). 2009, 14: 3159-3167.CrossRef Stehbens SJ, Akhmanova A, Yap AS: Microtubules and cadherins: a neglected partnership. Front Biosci (Landmark Ed). 2009, 14: 3159-3167.CrossRef
41.
go back to reference Han SP, Yap AS: The cytoskeleton and classical cadherin adhesions. Subcell Biochem. 2012, 60: 111-135.CrossRefPubMed Han SP, Yap AS: The cytoskeleton and classical cadherin adhesions. Subcell Biochem. 2012, 60: 111-135.CrossRefPubMed
42.
go back to reference Shtutman M, Chausovsky A, Prager-Khoutorsky M, Schiefermeier N, Boguslavsky S, Kam Z, Fuchs E, Geiger B, Borisy GG, Bershadsky AD: Signaling function of alpha-catenin in microtubule regulation. Cell Cycle. 2008, 7 (15): 2377-2383.CrossRefPubMedPubMedCentral Shtutman M, Chausovsky A, Prager-Khoutorsky M, Schiefermeier N, Boguslavsky S, Kam Z, Fuchs E, Geiger B, Borisy GG, Bershadsky AD: Signaling function of alpha-catenin in microtubule regulation. Cell Cycle. 2008, 7 (15): 2377-2383.CrossRefPubMedPubMedCentral
43.
go back to reference Rodríguez Rigueiro T, Valladares Ayerbes M, Haz Conde M, Blanco M, Aparicio G, Fernández Puente P, Blanco FJ, Lorenzo MJ, Aparicio LA, Figueroa A: A novel procedure for protein extraction from formalin-fixed paraffin-embedded tissues. Proteomics. 2011, 11 (12): 2555-2559.CrossRefPubMed Rodríguez Rigueiro T, Valladares Ayerbes M, Haz Conde M, Blanco M, Aparicio G, Fernández Puente P, Blanco FJ, Lorenzo MJ, Aparicio LA, Figueroa A: A novel procedure for protein extraction from formalin-fixed paraffin-embedded tissues. Proteomics. 2011, 11 (12): 2555-2559.CrossRefPubMed
44.
go back to reference Bonfil RD, Russo DM, Binda MM, Delgado FM, Vincenti M: Higher antitumor activity of vinflunine than vinorelbine against an orthotopic murine model of transitional cell carcinoma of the bladder. Urol Oncol. 2002, 7 (4): 159-166.CrossRefPubMed Bonfil RD, Russo DM, Binda MM, Delgado FM, Vincenti M: Higher antitumor activity of vinflunine than vinorelbine against an orthotopic murine model of transitional cell carcinoma of the bladder. Urol Oncol. 2002, 7 (4): 159-166.CrossRefPubMed
45.
go back to reference Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D, Goldberg AL: Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 1994, 78 (5): 761-771.CrossRefPubMed Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D, Goldberg AL: Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 1994, 78 (5): 761-771.CrossRefPubMed
46.
go back to reference Zhang Z, Zhou Y, Qian H, Shao G, Lu X, Chen Q, Sun X, Chen D, Yin R, Zhu H, Shao Q, Xu W: Stemness and inducing differentiation of small cell lung cancer NCI-H446 cells. Cell Death Dis. 2013, 4: e633-CrossRefPubMedPubMedCentral Zhang Z, Zhou Y, Qian H, Shao G, Lu X, Chen Q, Sun X, Chen D, Yin R, Zhu H, Shao Q, Xu W: Stemness and inducing differentiation of small cell lung cancer NCI-H446 cells. Cell Death Dis. 2013, 4: e633-CrossRefPubMedPubMedCentral
47.
go back to reference Guichet PO, Bieche I, Teigell M, Serguera C, Rothhut B, Rigau V, Scamps F, Ripoll C, Vacher S, Taviaux S, Chevassus H, Duffau H, Mallet J, Susini A, Joubert D, Bauchet L, Hugnot JP: Cell death and neuronal differentiation of glioblastoma stem-like cells induced by neurogenic transcription factors. Glia. 2013, 61 (2): 225-239.CrossRefPubMed Guichet PO, Bieche I, Teigell M, Serguera C, Rothhut B, Rigau V, Scamps F, Ripoll C, Vacher S, Taviaux S, Chevassus H, Duffau H, Mallet J, Susini A, Joubert D, Bauchet L, Hugnot JP: Cell death and neuronal differentiation of glioblastoma stem-like cells induced by neurogenic transcription factors. Glia. 2013, 61 (2): 225-239.CrossRefPubMed
48.
go back to reference Campos B, Wan F, Farhadi M, Ernst A, Zeppernick F, Tagscherer KE, Ahmadi R, Lohr J, Dictus C, Gdynia G, Combs SE, Goidts V, Helmke BM, Eckstein V, Roth W, Beckhove P, Lichter P, Unterberg A, Radlwimmer B, Herold-Mende C: Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res. 2010, 16 (10): 2715-2728.CrossRefPubMed Campos B, Wan F, Farhadi M, Ernst A, Zeppernick F, Tagscherer KE, Ahmadi R, Lohr J, Dictus C, Gdynia G, Combs SE, Goidts V, Helmke BM, Eckstein V, Roth W, Beckhove P, Lichter P, Unterberg A, Radlwimmer B, Herold-Mende C: Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res. 2010, 16 (10): 2715-2728.CrossRefPubMed
49.
go back to reference Seigel GM: Differentiation potential of human retinoblastoma cells. Curr Pharm Biotechnol. 2011, 12 (2): 213-216.CrossRefPubMed Seigel GM: Differentiation potential of human retinoblastoma cells. Curr Pharm Biotechnol. 2011, 12 (2): 213-216.CrossRefPubMed
50.
go back to reference Okouneva T, Hill BT, Wilson L, Jordan MA: The effects of vinflunine, vinorelbine, and vinblastine on centromere dynamics. Mol Cancer Ther. 2003, 2 (5): 427-436.PubMed Okouneva T, Hill BT, Wilson L, Jordan MA: The effects of vinflunine, vinorelbine, and vinblastine on centromere dynamics. Mol Cancer Ther. 2003, 2 (5): 427-436.PubMed
51.
52.
go back to reference Debnath J, Brugge JS: Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer. 2005, 5 (9): 675-688.CrossRefPubMed Debnath J, Brugge JS: Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer. 2005, 5 (9): 675-688.CrossRefPubMed
53.
go back to reference Deep G, Gangar S, Agarwal C, Agarwal R: Role of E-cadherin in anti-migratory and anti-invasive efficacy of silibinin in prostate cancer cells. Cancer Prev Res (Phila). 2011, 4 (8): 1222-1232.CrossRef Deep G, Gangar S, Agarwal C, Agarwal R: Role of E-cadherin in anti-migratory and anti-invasive efficacy of silibinin in prostate cancer cells. Cancer Prev Res (Phila). 2011, 4 (8): 1222-1232.CrossRef
54.
go back to reference Wu K, Zeng J, Li L, Fan J, Zhang D, Xue Y, Zhu G, Yang L, Wang X, He D: Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors. Oncol Rep. 2010, 23 (6): 1545-1552.CrossRefPubMed Wu K, Zeng J, Li L, Fan J, Zhang D, Xue Y, Zhu G, Yang L, Wang X, He D: Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors. Oncol Rep. 2010, 23 (6): 1545-1552.CrossRefPubMed
55.
go back to reference Black PC, Brown GA, Inamoto T, Shrader M, Arora A, Siefker-Radtke AO, Adam L, Theodorescu D, Wu X, Munsell MF, Bar-Eli M, McConkey DJ, Dinney CP: Sensitivity to epidermal growth factor receptor inhibitor requires E-cadherin expression in urothelial carcinoma cells. Clin Cancer Res. 2008, 14 (5): 1478-1486.CrossRefPubMed Black PC, Brown GA, Inamoto T, Shrader M, Arora A, Siefker-Radtke AO, Adam L, Theodorescu D, Wu X, Munsell MF, Bar-Eli M, McConkey DJ, Dinney CP: Sensitivity to epidermal growth factor receptor inhibitor requires E-cadherin expression in urothelial carcinoma cells. Clin Cancer Res. 2008, 14 (5): 1478-1486.CrossRefPubMed
56.
go back to reference Laplante I, Béliveau R, Paquin J: RhoA/ROCK and Cdc42 regulate cell-cell contact and N-cadherin protein level during neurodetermination of P19 embryonal stem cells. J Neurobiol. 2004, 60 (3): 289-307.CrossRefPubMed Laplante I, Béliveau R, Paquin J: RhoA/ROCK and Cdc42 regulate cell-cell contact and N-cadherin protein level during neurodetermination of P19 embryonal stem cells. J Neurobiol. 2004, 60 (3): 289-307.CrossRefPubMed
57.
go back to reference Lehmann M, Fournier A, Selles-Navarro I, Dergham P, Sebok A, Leclerc N, Tigyi G, McKerracher L: Inactivation of Rho signaling pathway promotes CNS axon regeneration. J Neurosci. 1999, 19 (17): 7537-7547.PubMed Lehmann M, Fournier A, Selles-Navarro I, Dergham P, Sebok A, Leclerc N, Tigyi G, McKerracher L: Inactivation of Rho signaling pathway promotes CNS axon regeneration. J Neurosci. 1999, 19 (17): 7537-7547.PubMed
59.
go back to reference Yuan XB, Jin M, Xu X, Song YQ, Wu CP, Poo MM, Duan S: Signalling and crosstalk of Rho GTPases in mediating axon guidance. Nat Cell Biol. 2003, 5 (1): 38-45.CrossRefPubMed Yuan XB, Jin M, Xu X, Song YQ, Wu CP, Poo MM, Duan S: Signalling and crosstalk of Rho GTPases in mediating axon guidance. Nat Cell Biol. 2003, 5 (1): 38-45.CrossRefPubMed
60.
go back to reference Gao X, Bian W, Yang J, Tang K, Kitani H, Atsumi T, Jing N: A role of N-cadherin in neuronal differentiation of embryonic carcinoma P19 cells. Biochem Biophys Res Commun. 2001, 284 (5): 1098-1103.CrossRefPubMed Gao X, Bian W, Yang J, Tang K, Kitani H, Atsumi T, Jing N: A role of N-cadherin in neuronal differentiation of embryonic carcinoma P19 cells. Biochem Biophys Res Commun. 2001, 284 (5): 1098-1103.CrossRefPubMed
61.
go back to reference Kitase Y, Shuler CF: Microtubule disassembly prevents palatal fusion and alters regulation of the E-cadherin/catenin complex. Int J Dev Biol. 2013, 57 (1): 55-60.CrossRefPubMed Kitase Y, Shuler CF: Microtubule disassembly prevents palatal fusion and alters regulation of the E-cadherin/catenin complex. Int J Dev Biol. 2013, 57 (1): 55-60.CrossRefPubMed
62.
go back to reference Kitase Y, Shuler CF: Multi-layered hypertrophied MEE formation by microtubule disruption via GEF-H1/RhoA/ROCK signaling pathway. Dev Dyn. 2012, 241 (7): 1169-1182.CrossRefPubMed Kitase Y, Shuler CF: Multi-layered hypertrophied MEE formation by microtubule disruption via GEF-H1/RhoA/ROCK signaling pathway. Dev Dyn. 2012, 241 (7): 1169-1182.CrossRefPubMed
63.
go back to reference Brieher WM, Yap AS: Cadherin junctions and their cytoskeleton(s). Curr Opin Cell Biol. 2013, 25 (1): 39-46.CrossRefPubMed Brieher WM, Yap AS: Cadherin junctions and their cytoskeleton(s). Curr Opin Cell Biol. 2013, 25 (1): 39-46.CrossRefPubMed
64.
go back to reference Meng W, Mushika Y, Ichii T, Takeichi M: Anchorage of microtubule minus ends to adherens junctions regulates epithelial cell-cell contacts. Cell. 2008, 135 (5): 948-959.CrossRefPubMed Meng W, Mushika Y, Ichii T, Takeichi M: Anchorage of microtubule minus ends to adherens junctions regulates epithelial cell-cell contacts. Cell. 2008, 135 (5): 948-959.CrossRefPubMed
65.
go back to reference Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, Knuechel R, Kirchner T: Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A. 2001, 98 (18): 10356-10361.CrossRefPubMedPubMedCentral Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, Knuechel R, Kirchner T: Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A. 2001, 98 (18): 10356-10361.CrossRefPubMedPubMedCentral
66.
go back to reference Chaffer CL, Brennan JP, Slavin JL, Blick T, Thompson EW, Williams ED: Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res. 2006, 66 (23): 11271-11278.CrossRefPubMed Chaffer CL, Brennan JP, Slavin JL, Blick T, Thompson EW, Williams ED: Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res. 2006, 66 (23): 11271-11278.CrossRefPubMed
67.
go back to reference Ocaña OH, Córcoles R, Fabra A, Moreno-Bueno G, Acloque H, Vega S, Barrallo-Gimeno A, Cano A, Nieto MA: Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell. 2012, 22 (6): 709-724.CrossRefPubMed Ocaña OH, Córcoles R, Fabra A, Moreno-Bueno G, Acloque H, Vega S, Barrallo-Gimeno A, Cano A, Nieto MA: Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell. 2012, 22 (6): 709-724.CrossRefPubMed
68.
go back to reference Tsai JH, Donaher JL, Murphy DA, Chau S, Yang J: Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell. 2012, 22 (6): 725-736.CrossRefPubMedPubMedCentral Tsai JH, Donaher JL, Murphy DA, Chau S, Yang J: Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell. 2012, 22 (6): 725-736.CrossRefPubMedPubMedCentral
69.
go back to reference Brabletz T: EMT and MET in metastasis: where are the cancer stem cells?. Cancer Cell. 2012, 22 (6): 699-701.CrossRefPubMed Brabletz T: EMT and MET in metastasis: where are the cancer stem cells?. Cancer Cell. 2012, 22 (6): 699-701.CrossRefPubMed
70.
go back to reference Nieto MA, Cano A: The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity. Semin Cancer Biol. 2012, 22 (5–6): 361-368.CrossRefPubMed Nieto MA, Cano A: The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity. Semin Cancer Biol. 2012, 22 (5–6): 361-368.CrossRefPubMed
Metadata
Title
Role of the microtubule-targeting drug vinflunine on cell-cell adhesions in bladder epithelial tumour cells
Authors
Luis A Aparicio
Raquel Castosa
Mar Haz-Conde
Marta Rodríguez
Moisés Blanco
Manuel Valladares
Angélica Figueroa
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2014
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-14-507

Other articles of this Issue 1/2014

BMC Cancer 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine